High Grade Astrocytic Tumor — Trials

High Grade Astrocytic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

1,778 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 495
Recruiting: 263
Ph III recruiting: 15
Growth YoY: +41.8%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 401–450 of 1,778 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06504381	DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma	recruiting	Phase 1 / Phase 2	70	University of California, San FranciscoOTHER	1	Mar 11, 2026	clinicaltrials
NCT04716699	Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma	completed	Phase 1	12	University of California, DavisOTHER	1	Mar 10, 2026	clinicaltrials